Cite
HARVARD Citation
Topp, M. et al. (2021). Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab. Cancer. 127 (4), pp. 554-559. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Topp, M. et al. (2021). Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab. Cancer. 127 (4), pp. 554-559. [Online].